Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VIKASLIFE.NS Stock Summary
Top 10 Correlated ETFs
VIKASLIFE.NS
In the News
VIKASLIFE.NS Financial details
Company Rating
-
Market Cap
7.18B
Income
-16.25M
Revenue
4.67B
Book val./share
2.89
Cash/share
0.1
Dividend
-
Dividend %
-
Employees
59
Optionable
No
Shortable
Yes
Earnings
23 Jan 2024
P/E
-375.47
Forward P/E
-
PEG
34.23
P/S
1.54
P/B
1.73
P/C
50
P/FCF
-
Quick Ratio
2.16
Current Ratio
2.51
Debt / Equity
0.07
LT Debt / Equity
0.04
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
-138.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
17.42%
Revenue Q/Q
17.33%
EPS Q/Q
-25%
-
-
-
-
SMA20
4.61%
SMA50
-10.41%
SMA100
60.45%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-0.01%
Gross Margin
6%
Oper. Margin
-1%
Profit Margin
-
Payout
-
Shs Outstand
1.44B
Shs Float
1.27B
-
-
-
-
Target Price
-
52W Range
2.7-7.05
52W High
-28.57%
52W Low
+150%
RSI
50.09
Rel Volume
0.56
Avg Volume
26.9M
Volume
14.98M
Perf Week
-0.99%
Perf Month
12.36%
Perf Quarter
53.85%
Perf Half Y
75.44%
-
-
-
-
Beta
1.436
-
-
Volatility
0.05%, 0.2%
Prev Close
-0.99%
Price
5
Change
1.01%
VIKASLIFE.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.68 | 1.7 | 0.94 | 3.22 | 3.65 | |
Net income per share | 0.02 | 0.02 | -0.04 | 0.31 | -0.12 | |
Operating cash flow per share | -0.15 | 0.04 | -0.1 | -0.16 | -0.84 | |
Free cash flow per share | -0.16 | 0.04 | -0.12 | -0.3 | -0.98 | |
Cash per share | 0.08 | 0 | 0 | 0.11 | 0.09 | |
Book value per share | 1.13 | 0.58 | 0.84 | 2.13 | 2.54 | |
Tangible book value per share | 1.13 | 0.58 | 0.84 | 1.96 | 2.41 | |
Share holders equity per share | 1.13 | 0.58 | 0.84 | 2.13 | 2.54 | |
Interest debt per share | 0.56 | 0.5 | 0.57 | 0.26 | 0.25 | |
Market cap | 4.1B | 1.1B | 2.04B | 4.95B | 4.38B | |
Enterprise value | 4.47B | 1.5B | 2.45B | 5.11B | 4.58B | |
P/E ratio | 212.67 | 78.59 | -58.14 | 17.26 | -28.6 | |
Price to sales ratio | 1.92 | 0.71 | 2.71 | 1.65 | 0.92 | |
POCF ratio | -35.29 | 29.12 | -26.5 | -33.27 | -3.97 | |
PFCF ratio | -32.75 | 33.59 | -22.24 | -17.62 | -3.43 | |
P/B Ratio | 4.55 | 2.05 | 3.05 | 2.48 | 1.32 | |
PTB ratio | 4.55 | 2.05 | 3.05 | 2.48 | 1.32 | |
EV to sales | 2.1 | 0.97 | 3.27 | 1.7 | 0.96 | |
Enterprise value over EBITDA | 45.42 | 12.26 | 33.5 | 988.79 | -28.54 | |
EV to operating cash flow | -38.53 | 39.82 | -31.91 | -34.31 | -4.16 | |
EV to free cash flow | -35.76 | 45.93 | -26.79 | -18.17 | -3.59 | |
Earnings yield | 0 | 0.01 | -0.02 | 0.06 | -0.03 | |
Free cash flow yield | -0.03 | 0.03 | -0.04 | -0.06 | -0.29 | |
Debt to equity | 0.44 | 0.76 | 0.63 | 0.12 | 0.09 | |
Debt to assets | 0.16 | 0.16 | 0.28 | 0.07 | 0.07 | |
Net debt to EBITDA | 3.83 | 3.29 | 5.68 | 29.77 | -1.3 | |
Current ratio | 1.28 | 0.88 | 1.41 | 1.26 | 2.14 | |
Interest coverage | 1.11 | 1.75 | 1.82 | -1.78 | -8.28 | |
Income quality | -4.14 | 1.5 | 5.12 | -0.38 | 5.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.01 | 0.02 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0 | 0 | 0.05 | 0.04 | |
Capex to operating cash flow | 0.08 | -0.13 | 0.19 | 0.89 | 0.16 | |
Capex to revenue | 0 | 0 | -0.02 | -0.04 | -0.04 | |
Capex to depreciation | -1.25 | -0.68 | -2.15 | -9.57 | -5.8 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.79 | 0.45 | 0.91 | 3.84 | 2.59 | |
ROIC | 0.03 | 0.05 | 0.15 | -0.01 | -0.04 | |
Return on tangible assets | 0.01 | 0.01 | -0.02 | 0.09 | -0.04 | |
Graham Net | -0.27 | -0.91 | -0.86 | -0.27 | 0.26 | |
Working capital | 404.81M | -235.92M | 273.43M | 273.38M | 1.21B | |
Tangible asset value | 794.32M | 535.23M | 666.7M | 1.83B | 3.14B | |
Net current asset value | 321.17M | -342.51M | 109.94M | 110.5M | 1.06B | |
Invested capital | 0.44 | 0.76 | 0.63 | 0.12 | 0.09 | |
Average receivables | 892.13M | 1.43B | 681.86M | 480.27M | 1.39B | |
Average payables | 496.31M | 1.06B | 799.73M | 521.49M | 627.22M | |
Average inventory | 170.2M | 292.82M | 287.51M | 278.31M | 205.1M | |
Days sales outstanding | 257.78 | 320.82 | 0 | 116.51 | 139.84 | |
Days payables outstanding | 163.94 | 315.19 | 215.57 | 83.66 | 47.51 | |
Days of inventory on hand | 51.25 | 78.17 | 155.55 | 35.76 | 10.12 | |
Receivables turnover | 1.42 | 1.14 | 0 | 3.13 | 2.61 | |
Payables turnover | 2.23 | 1.16 | 1.69 | 4.36 | 7.68 | |
Inventory turnover | 7.12 | 4.67 | 2.35 | 10.21 | 36.05 | |
ROE | 0.02 | 0.03 | -0.05 | 0.14 | -0.05 | |
Capex per share | -0.01 | -0.01 | -0.02 | -0.14 | -0.13 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.01 | 1.14 | 0.97 | 0.66 | 0.95 | |
Net income per share | 0.02 | 0.05 | -0.22 | 0.08 | 0.06 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.07 | 0 | 0.09 | 0 | 0.1 | |
Book value per share | 2.35 | 0 | 2.72 | 0 | 2.89 | |
Tangible book value per share | 2.23 | 0 | 2.58 | 0 | 2.65 | |
Share holders equity per share | 2.35 | 0 | 2.72 | 0 | 2.89 | |
Interest debt per share | 0.1 | 0 | 0.26 | 0 | 0.21 | |
Market cap | 5.94B | 5.24B | 4.09B | 4.67B | 6.53B | |
Enterprise value | 6.02B | 0 | 4.29B | 0 | 6.73B | |
P/E ratio | 63.19 | 22.25 | -3.8 | 9.69 | 22.29 | |
Price to sales ratio | 4.51 | 3.91 | 3.46 | 4.72 | 5.63 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 1.94 | 0 | 1.23 | 0 | 1.85 | |
PTB ratio | 1.94 | 0 | 1.23 | 0 | 1.85 | |
EV to sales | 4.56 | 0 | 3.64 | 0 | 5.8 | |
Enterprise value over EBITDA | 104.19 | 0 | -14.08 | 0 | 73.15 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0.01 | -0.07 | 0.03 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.04 | 0 | 0.09 | 0 | 0.07 | |
Debt to assets | 0.03 | 0 | 0.07 | 0 | 0.06 | |
Net debt to EBITDA | 1.24 | 0 | -0.68 | 0 | 2.21 | |
Current ratio | 1.99 | 0 | 2.14 | 0 | 2.51 | |
Interest coverage | 18.71 | 7.74 | -25.78 | 26.96 | 12.62 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0 | 0.04 | 0 | 0.07 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.97 | 0 | 3.67 | 0 | 1.97 | |
ROIC | 0.01 | 0 | -0.07 | 0 | 0.02 | |
Return on tangible assets | 0.01 | 0 | -0.06 | 0 | 0.02 | |
Graham Net | 0.01 | 0 | 0.27 | 0 | 0.29 | |
Working capital | 865.6M | 0 | 1.21B | 0 | 1.23B | |
Tangible asset value | 2.92B | 0 | 3.14B | 0 | 3.23B | |
Net current asset value | 686.51M | 0 | 1.06B | 0 | 1.02B | |
Invested capital | 0.04 | 0 | 0.09 | 0 | 0.07 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 77.42 | 0 | 138.99 | 0 | 126.96 | |
Days payables outstanding | 32.85 | 0 | 46.78 | 0 | 28.54 | |
Days of inventory on hand | 18.98 | 0 | 9.97 | 0 | 4.28 | |
Receivables turnover | 1.16 | 0 | 0.65 | 0 | 0.71 | |
Payables turnover | 2.74 | 0 | 1.92 | 0 | 3.15 | |
Inventory turnover | 4.74 | 0 | 9.03 | 0 | 21.02 | |
ROE | 0.01 | 0 | -0.08 | 0 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
VIKASLIFE.NS Frequently Asked Questions
What is Vikas Lifecare Limited stock symbol ?
Vikas Lifecare Limited is a IN stock and trading under the symbol VIKASLIFE.NS
What is Vikas Lifecare Limited stock quote today ?
Vikas Lifecare Limited stock price is $5 today.
Is Vikas Lifecare Limited stock public?
Yes, Vikas Lifecare Limited is a publicly traded company.